(CBS19 NEWS) -- While the use of GLP-1 receptor agonists and other weight loss drugs continues to make headlines, a doctor at UVA Health said they aren't as accessible as people think
PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body processes and responds to GLP-1 agonists
As we have seen with GLP-1 drugs, once a therapy demonstrates both biological efficacy and real-world impact, adoption can accelerate very quickly. Whether through stem cell activation, immune modulation, reformulated legacy drugs, or regenerative medicine, the next generation of hair loss therapies is no longer chasing incremental improvement
Semaglutide and Diabetes Semaglutide for diabetes has already been approved by FDA after a series of successful trials called SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes)